“Real world outcomes of intravitreal brolucizumab for persistent diabetic macular edema”

Abstract Aim Chronic Persistent Diabetic Macular Edema can be a clinical challenge. The aim of this study is to assess the outcomes of intravitreal brolucizumab 6 mg/0.05 ml for persistent diabetic macular edema (P-DME) in a real-world clinical setting. Methods A prospective interventional trial of...

Full description

Bibliographic Details

Published in:	International Journal of Retina and Vitreous
Main Authors:	Saarang Hansraj, Ritesh Narula, Vishal Ramesh Raval, Raja Narayanan, Mudit Tyagi
Format:	Article
Language:	English
Published:	BMC 2025-09-01
Subjects:	Persistent diabetic macular edema Brolucizumab anti-VEGF Optical coherence tomography Recalcitrant diabetic macular edema
Online Access:	https://doi.org/10.1186/s40942-025-00708-y